MLVAX
Price
$18.55
Change
-$0.42 (-2.21%)
Updated
Dec 18 closing price
VFINX
Price
$543.37
Change
-$16.51 (-2.95%)
Updated
Dec 18 closing price
Ad is loading...

MLVAX vs VFINX

Header iconMLVAX vs VFINX Comparison
Open Charts MLVAX vs VFINXBanner chart's image
MFS Low Volatility Equity A
Price$18.55
Change-$0.42 (-2.21%)
VolumeN/A
CapitalizationN/A
Vanguard 500 Index Investor
Price$543.37
Change-$16.51 (-2.95%)
VolumeN/A
CapitalizationN/A
MLVAX vs VFINX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MLVAX vs. VFINX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLVAX is a Hold and VFINX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.37T vs. MLVAX (403M). VFINX pays higher dividends than MLVAX: VFINX (1.24) vs MLVAX (0.83). MLVAX was incepted earlier than VFINX: MLVAX (11 years) vs VFINX (48 years). MLVAX is a more actively managed with annual turnover of: 39.00 vs. VFINX (2.00). VFINX has a lower initial minimum investment than MLVAX: VFINX (0) vs MLVAX (1000). VFINX annual gain was more profitable for investors over the last year : 27.63 vs. MLVAX (4.80). VFINX return over 5 years is better than : 88.65 vs. MLVAX (17.08).
MLVAXVFINXMLVAX / VFINX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years48 years-
Gain YTD3.78027.27514%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets403M1.37T0%
Annual Yield % from dividends0.831.2467%
Returns for 1 year4.8027.6317%
Returns for 3 years-9.9330.99-32%
Returns for 5 years17.0888.6519%
Returns for 10 years78.67193.6241%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LX6.090.31
+5.36%
LexinFintech Holdings Ltd
DDOG156.911.09
+0.70%
Datadog
PAR78.060.08
+0.10%
PAR Technology Corp
HRI195.00-4.00
-2.01%
Herc Holdings
BRNS0.92-0.05
-5.26%
Barinthus Biotherapeutics plc